LMI’s Guide: Multipotent Stem Cells and Cancer Prevention

At Longevity Medical Institute (LMI), we embrace the transformative potential of multipotent stem cells. Our therapies exclusively utilize these cells because they function like expert technicians—precisely targeting the areas that need repair without the unpredictable side effects associated with pluripotent cells. Whether employing placental MSCs for musculoskeletal repair, umbilical MSCs with potent anti-inflammatory properties, adipose-derived MSCs for soft tissue regeneration, or endometrial MSCs designed for women’s health, each cell type is carefully selected to match your unique needs. Our state-of-the-art biotechnology lab ensures complete transparency, providing detailed reports on the type of multipotent cell administered, the exact number of cells delivered, and their viability (live cells) rate, which consistently exceeds 98%. Longevity Medical Institute: Personalized and Transparent Stem Cell Therapies

Should You Use Stem Cells if You Have Active Cancer? For patients with active cancer, stem cell therapy is not an option. At LMI, we adhere to strict guidelines that prevent the use of stem cells until you have been in remission for at least five years. This precaution helps ensure that regenerative treatments do not inadvertently stimulate any residual cancer cells or interfere with ongoing cancer therapies. Instead, if cancer is present, we focus on targeted treatments like Natural Killer cell therapy, which are designed to actively combat malignant cells. Your safety is our highest priority, and we take every measure to deliver the most appropriate and effective treatment based on your specific health status.

Longevity Medical Institute (C) Copyright. All Rights Reserved.

06

Made with FlippingBook - Share PDF online